| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| halothane | Inhalation | N/A | |
| isoflurane | Inhalation | N/A | |
| ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
| nitrous oxide | Inhalation | N/A | |
| oxygen | Inhalation (medicine gas) | N/A | |
| propofol | Injection | 1% | |
| sevoflurane | Inhalation | N/A | |
| thiopental | Injection | 1 g (as sodium) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bupivacaine | Injection | 0.5% (hydrochloride) with preservant | |
| bupivacaine | Injection | 0.5% (hydrochloride) without preservant | |
| bupivacaine | Injection for spinal anaesthesia | 0.5% (hydrochloride) in 20-ml ampoule to be mixed with 7.5% glucose solution | |
| lidocaine | Dental cartridge | 2% (hydrochloride) | |
| lidocaine | Injection | 2% (hydrochloride) + epinephrine 1:200 000 in vial + preservant | |
| lidocaine | Injection | 2% (hydrochloride) in vial | |
| lidocaine | Injection | 2% (hydrochloride) with preservant | |
| lidocaine | Topical forms | 2% to 4% (hydrochloride) | |
| lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:80 000 | |
| lidocaine + epinephrine (adrenaline) | Injection | 2% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | Tablet (scored) | 10 mg | |
| ethylephrine | Injection | 10mg/ml | |
| fentanyl | Injection | 50 mcg (citrate)/mL | |
| midazolam | Injection | 1 mg/ml | |
| midazolam | Injection | 5 mg/mL | |
| morphine | Injection | 10 mg (hydrochloride)/mL | |
| promethazine | Injection | 25mg (hydrochloride)/ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 500 mg | |
| diclofenac | Injection | 25 mg (sodium)/mL | |
| dipyrone (metamizole sodium) | Injection | 500 mg/ml | |
| ibuprofen | Suspension | 100 mg/5 mL | |
| ibuprofen | Tablet | 200 mg | |
| ibuprofen | Tablet | 400 mg | |
| naproxen | Tablet | 250 mg (sodium) | |
| naproxen | Tablet | 500 mg (sodium) | |
| paracetamol | Oral liquid | 120 mg/5 mL | |
| paracetamol | Oral solution (drops) | 100mg/ml | |
| paracetamol | Suppository | 100-300mg | |
| paracetamol | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| codeine | Injection | 30mg (phosphate)/ml | |
| codeine | Oral liquid | 10-15mg (phosphate)/5ml | |
| codeine | Tablet | 30 mg (phosphate) | |
| codeine | Tablet | 60mg (phosphate) | |
| morphine | Injection | 10 mg (hydrochloride)/mL | |
| morphine | Injection | 20 mg (hydrochloride)/mL | |
| morphine | Oral liquid | 10 mg (sulfate)/5 mL | |
| morphine | Tablet | 10 mg - 200 mg (morphine sulfate) | |
| morphine | Tablet | 30 mg (sulfate) | |
| morphine | Tablet (prolonged release) | 30 mg (morphine sulfate) | |
| oxycodone | Tablet | 5mg (hydrochloride) | |
| tramadol | Injection | 50 mg (hydrochloride)/mL | |
| tramadol | Oral liquid | 100 mg (hydrochloride)/mL (as drops) | |
| tramadol | Tablet | 50 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| allopurinol | Tablet | 100 mg | |
| allopurinol | Tablet | 300 mg | |
| colchicine | Tablet | 0.5mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aurothiomalate | Injection | 50mg (sodium)/ml | |
| hydroxychloroquine | Tablet | 400mg (sulfate) or 310mg (pure) | |
| penicillamine | Solid oral dosage form | 250 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chlorphenamine | Injection | 10mg (maleate)/ml | |
| chlorphenamine | Oral liquid | 1mg (maleate)/ml | |
| chlorphenamine | Oral liquid | 2 mg/5 ml (hydrogen maleate) | |
| chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
| dexamethasone | Injection | 4 mg/mL in 1-mL ampoule (as disodium phosphate salt) | |
| epinephrine (adrenaline) | Injection | 1 mg (as hydrochloride or hydrogen tartrate) in 1-ml ampoule | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
| loratadine | Oral liquid | 5 mg/mL | |
| loratadine | Tablet | 10 mg | |
| methylprednisolone | Injection | 500 mg (sodium succinate) | |
| prednisone | Tablet | 20 mg | |
| prednisone | Tablet | 5 mg | |
| prednisone | Tablet | 50 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| charcoal, activated | Powder | N/A | |
| ipecacuanha | Oral liquid | 0.14% (7mg/5ml) total alkaloids |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylcysteine | Injection | 200 mg/ml in 10-ml ampoule | |
| amyl nitrite | Inhalation | N/A | |
| atropine | Injection | 0.5 mg/mL | |
| atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
| calcium gluconate | Injection | 10% | |
| cyanocobalamin | Injection | 1 mg/ml | |
| dantrolene | Injection | 20 mg (sodium) | |
| deferoxamine | Powder for injection | 500 mg (mesilate) in vial | |
| dimercaprol | Injection in oil | 50 mg/mL in 2-mL ampoule | |
| flumazenil | Injection | 100mcg/ml | |
| methionine | Tablet | 250mg | |
| methylthioninium chloride (methylene blue) | Injection | 10 mg/ml | |
| naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
| penicillamine | Solid oral dosage form | 250 mg | |
| potassium ferric hexacyano-ferrate(II) - 2H20 (Prussian blue) | Tablet | 500mg | |
| pralidoxime | Injection | 1g (chlorohydrate) | |
| sodium calcium edetate | Injection | 200 mg/ml in 5-ml ampoule | |
| sodium nitrite | Injection | 30 mg/mL in 10-mL ampoule | |
| sodium thiosulfate | Injection | 250 mg/mL in 50-mL ampoule | |
| succimer | Solid oral dosage form | 100 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| carbamazepine | Oral liquid | 100 mg/5 ml | |
| carbamazepine | Tablet (scored) | 200 mg | |
| clonazepam | Tablet | 2mg | |
| clonazepam | Tablet | 500mcg | |
| diazepam | Injection | 5 mg/mL | |
| ethosuximide | Oral liquid | 250 mg/5 ml | |
| ethosuximide | Tablet | 250 mg | |
| gabapentin | Solid oral dosage form | 300 mg | |
| lamotrigine | Tablet | 50 mg | |
| magnesium sulfate | Injection | 200 mg/mL in 10-mL ampoule | |
| magnesium sulfate | Injection | 500 mg/mL in 10-mL ampoule | |
| phenobarbital | Injection | 100 mg (sodium)/mL in 2-mL ampoule | |
| phenobarbital | Tablet | 100 mg | |
| phenytoin | Injection | 50 mg/mL in 2-mL vial (sodium salt) | |
| phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
| phenytoin | Oral liquid | 125 mg/5 mL | |
| phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
| valproic acid (sodium valproate) | Oral liquid | 200 mg/5 ml | |
| valproic acid (sodium valproate) | Solution | 250 mg/5 mL | |
| valproic acid (sodium valproate) | Tablet (enteric-coated) | 500 mg (sodium valproate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| albendazole | Oral liquid | 100mg/5ml | |
| albendazole | Tablet | 200mg | |
| albendazole | Tablet (chewable) | 400 mg | |
| ivermectin | Oral liquid | 6mg/ml (drops) | |
| ivermectin | Tablet (scored) | 6 mg | |
| praziquantel | Tablet | 150 mg | |
| praziquantel | Tablet | 600 mg | |
| triclabendazole | Tablet | 250 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amipicillin + sulbactam | Injection | 1g (sodium) + 500mg (sodium) | |
| amoxicillin | Oral liquid | 250 mg/5 mL | |
| amoxicillin | Suspension | 500 mg/5 mL | |
| amoxicillin | Tablet | 500 mg | |
| amoxicillin + clavulanic acid | Oral liquid | 250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml | |
| amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
| ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
| ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
| benzathine benzylpenicillin | Injection | 1 200 000 IU | |
| benzathine benzylpenicillin | Injection | 2 400 000 IU | |
| dicloxacillin | Oral liquid | 250mg/5ml | |
| dicloxacillin | Tablet | 250mg | |
| dicloxacillin | Tablet | 500mg | |
| oxacillin | Injection | 1g | |
| oxacillin | Injection | 500mg | |
| phenoxymethylpenicillin | Oral liquid | 300,000 IU (as potassium)/5ml | |
| phenoxymethylpenicillin | Tablet | 1,000,000 IU (as potassium) | |
| potassium benzylpenicillin | Powder for injection | 5,000,000 IU | |
| procaine benzylpenicillin | Powder for injection | 1 g (=1 million IU) in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| cefalexin | Oral liquid | 250 mg/5 mL | |
| cefalexin | Tablet | 500 mg | |
| cefazolin | Powder for injection | 1 g (as sodium salt) in vial | |
| cefazolin | Powder for injection | 250 mg (as sodium salt) | |
| cefotaxime | Injection | 500 mg (as sodium salt) | |
| ceftazidime | Injection | 1 g | |
| ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
| ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial | |
| cefuroxime | Suspension | 250 mg (axetil)/5 mL | |
| cefuroxime | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| imipenem + cilastatin | Injection | 500mg + 500mg (as sodium) | |
| meropenem | Injection | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| azithromycin | Oral liquid | 200 mg/5 mL | |
| azithromycin | Tablet | 500 mg | |
| clarithromycin | Solid oral dosage form | 500 mg | |
| clarithromycin | Suspension | 250 mg/5 ml | |
| clindamycin | Injection | 150 mg (as phosphate)/mL | |
| clindamycin | Oral liquid | 75 mg/5 mL (as palmitate) | |
| clindamycin | Tablet | 300 mg (as chlorohydrate) | |
| erythromycin | Oral liquid | (as stearate or ethylsuccinate)/5ml | |
| erythromycin | Oral liquid | 200-250 mg (as stearate or ethylsuccinate)/5ml | |
| erythromycin | Tablet | 500 mg (as stearate or ethylsuccinate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amikacin | Injection | 250 mg (as sulfate)/mL in 2-mL vial | |
| amikacin | Injection | 50 mg (as sulfate)/mL in 2-mL vial | |
| gentamicin | Injection | 10 mg (sulfate)/mL in 2-mL vial | |
| gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 10-mL ampoule | |
| sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
| sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
| sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ciprofloxacin | Injection | 2mg (lactate)/ml | |
| ciprofloxacin | Tablet | 500mg (as chlorohydrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| doxycycline | Tablet | 100mg (chlorohydrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chloramphenicol | Capsule | 250 mg | |
| chloramphenicol | Capsule | 500 mg | |
| chloramphenicol | Oral liquid | 250 mg (palmitate)/5 mL | |
| chloramphenicol | Powder for injection | 1 g (sodium succinate) in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| furazolidone | Oral liquid | 50mg/ml | |
| furazolidone | Tablet | 100mg | |
| metronidazole | Injection | 5 mg/mL | |
| metronidazole | Oral liquid | 250 mg (benzoate)/5 mL | |
| metronidazole | Tablet | 500 mg | |
| nitrofurantoin | Oral liquid | 25 mg/5 ml | |
| nitrofurantoin | Tablet | 100 mg | |
| vancomycin | Injection | 500 mg (chlorohydrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clofazimine | Capsule | 100 mg | |
| clofazimine | Capsule | 50 mg | |
| dapsone | Tablet | 100 mg | |
| dapsone | Tablet | 50 mg | |
| rifampicin | Solid oral dosage form | 150 mg | |
| rifampicin | Solid oral dosage form | 300 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amikacin | Injection | 250 mg (as sulfate)/mL in 4 mL vial | |
| capreomycin | Injection | 1g | |
| ciprofloxacin | Tablet | 500mg (as chlorohydrate) | |
| cycloserine | Solid oral dosage form | 250 mg | |
| ethambutol | Tablet | 400mg (chlorohydrate) | |
| ethionamide | Tablet | 250 mg | |
| isoniazid | Tablet | 100mg | |
| kanamycin | Powder for injection | 1 g (as sulfate) in vial | |
| ofloxacin | Tablet | 200 mg | |
| p-aminosalicylate sodium (PAS sodium) | Granules | 800mg/g (equiv. 579.7 mg/g aminosalicylic acid) | |
| pyrazinamide | Tablet | 500 mg | |
| rifampicin | Oral liquid | 100mg/5ml | |
| rifampicin | Solid oral dosage form | 300 mg | |
| streptomycin | Injection | 1g (sulfate) | |
| streptomycin | Injection | 5 g (sulfate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amphotericin B | Powder for injection | 50 mg in vial | |
| clotrimazole | Vaginal tablet | 500 mg | |
| fluconazole | Injection | 2 mg/mL in vial | |
| fluconazole | Tablet | 150 mg | |
| griseofulvin | Solid oral dosage form | 250 mg | |
| itraconazole | Tablet | 100 mg | |
| nystatin | Oral liquid | 100 000 IU/ml | |
| nystatin | Tablet | 500 000 IU |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| abacavir (ABC) | Tablet | 300 mg | |
| didanosine (ddI) | Powder for oral liquid | 10mg/ml 2g | |
| didanosine (ddI) | Solid oral dosage form | 100mg | |
| didanosine (ddI) | Solid oral dosage form | 400mg | |
| lamivudine (3TC) | Oral liquid | 50 mg/5 ml | |
| lamivudine (3TC) | Tablet | 150 mg | |
| stavudine (d4T) | Capsule | 30 mg | |
| stavudine (d4T) | Powder for oral liquid | 5 mg/5 ml | |
| zidovudine (ZDV or AZT) | Oral liquid | 50 mg/5 mL | |
| zidovudine (ZDV or AZT) | Tablet | 100 mg | |
| zidovudine (ZDV or AZT) | Tablet | 300 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| efavirenz (EFV or EFZ) | Capsule | 200 mg | |
| efavirenz (EFV or EFZ) | Tablet | 600 mg | |
| nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
| nevirapine (NVP) | Tablet | 200 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| indinavir (IDV) | Solid oral dosage form | 400 mg (as sulfate) | |
| lamivudine + nevirapine + stavudine | Tablet | 150 mg + 200 mg + 30 mg | |
| lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
| lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
| lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
| lopinavir + ritonavir (LPV/r) | Tablet (heat stable) | 200 mg + 50 mg | |
| nelfinavir | Oral liquid | 50mg (mesylate)/g | |
| nelfinavir | Tablet | 250mg (as mesylate) | |
| ritonavir | Tablet (heat stable) | 100 mg | |
| saquinavir (SQV) | Solid oral dosage form | 200 mg (as mesilate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ganciclovir | Injection | 500 mg (sodium) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| diloxanide | Tablet | 500 mg (furoate) | |
| metronidazole | Oral liquid | 250 mg (benzoate)/5 mL | |
| metronidazole | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amphotericin B | Powder for injection | 50 mg in vial | |
| meglumine antimoniate | Solution for IV infusion injection | 85 mg/ml in ampoule | |
| pentamidine | Injection | 200 mg | |
| sodium stibogluconate | Injection | 100 mg/ml, 1 vial = 30 ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| artemether | Oily injection | 80 mg/ml in 1-ml ampoule | |
| artesunate | Suppository | 100mg | |
| artesunate | Tablet | 250mg | |
| artesunate | Tablet | 50 mg | |
| chloroquine | Tablet | 150mg (phosphate) | |
| doxycycline | Tablet | 100mg (chlorohydrate) | |
| mefloquine | Tablet | 250 mg (hydrochloride) | |
| primaquine | Tablet | 15 mg (phosphate) | |
| primaquine | Tablet | 5 mg (phosphate) | |
| primaquine | Tablet | 7.5 mg (phosphate) | |
| quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule | |
| quinine | Tablet | 300 mg (quinine sulfate) | |
| sulfadoxine + pyrimethamine | Tablet | 500 mg + 25 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| pyrimethamine | Tablet | 25 mg | |
| sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 5-mL ampoule | |
| sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| benznidazole | Tablet | 100 mg | |
| nifurtimox | Tablet | 120 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 500 mg | |
| ibuprofen | Tablet | 200 mg | |
| ibuprofen | Tablet | 400 mg | |
| paracetamol | Oral liquid | 120 mg/5 mL | |
| paracetamol | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amitriptyline | Tablet | 25 mg (hydrochloride) | |
| propranolol | Tablet | 10mg (hydrochloride) | |
| propranolol | Tablet | 40 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| azithromycin | Powder for oral suspension | 200 mg | |
| cyclosporine | Capsule (softgel) | 25mg | |
| cyclosporine | Capsule (softgel) | 50mg | |
| cyclosporine | Injection | 50mg/ml | |
| cyclosporine | Oral liquid | 100 mg/ml | |
| mycophenolate mofetil | Tablet | 250 mg | |
| mycophenolate mofetil | Tablet | 500 mg | |
| tacrolimus | Capsule | 1 mg | |
| tacrolimus | Injection | 5 mg/mL | |
| tacrolimus | Tablet | 5 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| asparaginase | Powder for injection | 10 000 IU in vial | |
| bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
| calcium folinate | Injection | equiv 50 mg folinic acid | |
| calcium folinate | Tablet | 15 mg | |
| capecitabine | Tablet | 500 mg | |
| carboplatin | Injection | 150 mg | |
| carboplatin | Injection | 450 mg | |
| carmustine | Injection | 100 mg | |
| chlorambucil | Tablet | 2 mg | |
| cisplatin | Powder for injection | 10 mg in vial | |
| cisplatin | Powder for injection | 50 mg in vial | |
| citarabine | Injection | 100 mg | |
| citarabine | Injection | 500 mg | |
| cyclophosphamide | Injection | 1 g | |
| cyclophosphamide | Injection | 200 mg | |
| cyclophosphamide | Tablet | 50 mg | |
| dacarbazine | Injection | 200 mg | |
| dacarbazine | Powder for injection | 100 mg in vial | |
| dactinomycin | Powder for injection | 500 mcg in vial | |
| daunorubicin | Injection | 20mg (chlorohydrate) | |
| dexrazoxane | Injection | 500mg (chlorohydrate) | |
| docetaxel | Injection | 20 mg/ml | |
| docetaxel | Injection | 80mg | |
| doxorubicin | Powder for injection | 10 mg (hydrochloride) in vial | |
| doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
| epirubicin | Injection | 10mg (chlorohydrate) | |
| epirubicin | Injection | 50mg (chlorohydrate) | |
| etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
| etoposide | Tablet | 50 mg | |
| filgrastim | Injection | 30,000,000 IU | |
| filgrastim | Injection | 48,000,000 IU | |
| fludarabine | Injection | 50 mg (phosphate) | |
| fluorouracil | Injection | 50 mg/ml in 10-ml ampoule | |
| fluorouracil | Injection | 50 mg/ml in 5-ml ampoule | |
| gemcitabine | Injection | 1g (chlorohydrate) | |
| gemcitabine | Injection | 200mg (chlorohydrate) | |
| hydroxycarbamide | Solid oral dosage form | 500 mg | |
| ifosfamide | Powder for injection | 1 g in vial | |
| imatinib | Tablet | 100 mg (as mesylate) | |
| imatinib | Tablet | 400 mg (as mesylate) | |
| melphalan | Tablet | 2 mg | |
| mercaptopurine | Tablet | 50 mg | |
| mesna | Injection | 100 mg/ml in 4-ml ampoules | |
| mesna | Tablet | 600 mg | |
| methotrexate | Injection | 500mg (sodium) | |
| methotrexate | Injection | 50mg (sodium) | |
| methotrexate | Injection | 50mg (sodium) + preservant | |
| methotrexate | Tablet | 2.5 mg (as sodium salt) | |
| mitomycin | Injection | 2 mg | |
| mitoxantrone | Injection | 20 mg (dichlorohydrate) | |
| oxaliplatin | Injection | 100 mg | |
| oxaliplatin | Injection | 50 mg | |
| paclitaxel | Injection | 100mg | |
| paclitaxel | Injection | 300 mg | |
| paclitaxel | Injection | 30mg | |
| procarbazine | Capsule | 50 mg (as hydrochloride) | |
| rituximab | Injection | 10 mg/mL in 10-mL vial | |
| rituximab | Injection | 10 mg/mL in 50-mL vial | |
| temozolomide | Tablet | 250mg | |
| thalidomide | Tablet | 100 mg | |
| thioguanine | Solid oral dosage form | 40 mg | |
| tretinoin | Tablet | 10mg | |
| vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
| vincristine | Powder for injection | 1 mg (sulfate) in vial | |
| vinorelbine | Injection | 50 mg (tartrate or ditartrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| anastrozole | Tablet | 1mg | |
| bicalutamide | Tablet | 150 mg | |
| bicalutamide | Tablet | 50 mg | |
| ciproterone | Tablet | 250 mg (acetate) | |
| dexamethasone | Injection | 4 mg/mL in 1-mL ampoule (as disodium phosphate salt) | |
| dexamethasone | Solid oral dosage form | 4 mg | |
| diethylstilbestrol | Tablet | 1 mg | |
| flutamide | Tablet | 250 mg | |
| leuprorelin | Injection | 7.5mg (acetate) | |
| medroxyprogesterone acetate | Injection | 500 mg | |
| medroxyprogesterone acetate | Tablet | 50 mg | |
| prednisone | Tablet | 20 mg | |
| prednisone | Tablet | 5 mg | |
| prednisone | Tablet | 50 mg | |
| tamoxifen | Tablet | 20 mg (as citrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| interferon alpha 2B | Injection | 3 000 000 IU with 1 mL diluent |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
| biperiden | Tablet | 2 mg (hydrochloride) | |
| levodopa + carbidopa | Tablet | 100 mg + 10 mg | |
| levodopa + carbidopa | Tablet | 250 mg + 25 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| cyanocobalamin | Injection | 0.1 mg/ ml | |
| epoetin alpha | Injection | 2000 IU/ml in 1ml vial | |
| epoetin alpha | Injection | 4000 IU/ml in 1ml vial | |
| ferrous salt + folic acid | Tablet | equivalent to 60 mg iron + 400 micrograms folic acid | |
| folic acid | Tablet | 0.5mg | |
| folic acid | Tablet | 1 mg | |
| iron | Injection | 20 mg (sacarate)/ml | |
| iron | Oral liquid | 15 mg (sulfate)/5ml | |
| iron | Oral liquid | 25 mg (sulfate)/ml | |
| iron | Tablet | 60 mg (sulfate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dalteparin | Injection | 25,000 IU (sodium)/ml | |
| enoxaparin | Injection | 100mg/ml in 0.4ml vial | |
| enoxaparin | Injection | 100mg/ml in 0.6ml vial | |
| heparin sodium | Injection | 5000 IU/mL in 5-mL vial | |
| phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
| protamine sulfate | Injection | 10 mg/mL in 5-mL ampoule | |
| tranexamic acid | Injection | 1g | |
| tranexamic acid | Tablet | 250mg | |
| warfarin | Tablet | 2.5 mg (sodium) | |
| warfarin | Tablet | 5 mg (sodium salt) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| polygeline | Injection | 3.5% in 500ml vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| factor VIII concentrate | Injection | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| diltiazem | Tablet | 60 mg (chlorohydrate) | |
| glyceryl trinitrate | Injection | 5 mg/mL | |
| isosorbide dinitrate | Tablet | 10 mg | |
| isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
| isosorbide mononitrate | Tablet | 20mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| adenosine | Injection | 3 mg/mL in 2-mL ampoule | |
| amiodarone | Injection | 50 mg/mL in 3-mL ampoule (hydrochloride) | |
| amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| digoxin | Tablet | 250 mcg | |
| lidocaine | Injection | 2% (without preservant) | |
| propafenone | Tablet | 150 mg | |
| verapamil | Injection | 2.5 mg (hydrochloride)/mL in 2-mL ampoule | |
| verapamil | Tablet | 80 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amlodipine | Tablet | 10 mg (besylate) | |
| amlodipine | Tablet | 5 mg (besylate) | |
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| captopril | Tablet | 25 mg | |
| enalapril | Tablet | 10 mg (maleate) | |
| enalapril | Tablet | 20 mg (maleate) | |
| hydrochlorothiazide | Solid oral dosage form | 25 mg | |
| losartan | Tablet | 50mg (potassium) | |
| methyldopa | Tablet | 250 mg | |
| nifedipine | Tablet (prolonged release) | 30mg | |
| sodium nitroprusside | Powder for infusion | 50 mg in ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bisoprolol | Tablet | 5mg (fumarate) | |
| carvedilol | Tablet | 25 mg | |
| carvedilol | Tablet | 6.25 mg | |
| digoxin | Oral liquid | 50 micrograms/mL | |
| digoxin | Tablet | 250 mcg | |
| dobutamine | Injection | 12.5mg (hydrochloride)/mL in 20 ml vial | |
| dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
| epinephrine (adrenaline) | Injection | 1 mg (as hydrochloride or hydrogen tartrate) in 1-ml ampoule | |
| furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Solid oral dosage form | 25 mg | |
| lanatoside C | Injection | 200mcg/ml | |
| norepinephrine | Injection | 1 mg/mL in 4-mL vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 80 to 100 mg | |
| alteplase | Injection | 50mg | |
| streptokinase | Powder for injection | 1.5 million IU in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atorvastatine | Tablet | 20 mg (calcium salt) | |
| atorvastatine | Tablet | 40 mg (calcium salt) | |
| gemfibrozil | Tablet | 600mg | |
| simvastatin | Tablet | 20 mg | |
| simvastatin | Tablet | 40 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| indomethacin | Injection | 1 mg (sodium salt) | |
| nimodipine | Capsule | 30 mg | |
| nimodipine | Injection | 0.2 mg/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clotrimazole | Cream | 1% | |
| clotrimazole | Solution | 1% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| fusidic acid | Cream | 2% | |
| mupirocin | Ointment | 2% | |
| nitrofural | Cream | 0.2% (35g) | |
| nitrofural | Cream | 0.2% (500g) | |
| silver sulfadiazine | Cream | 1% (400-500g) | |
| silver sulfadiazine | Cream | 1% (50g) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clobetasol | Cream | 0.05% | |
| hydrocortisone | Cream | 1% (acetate) | |
| triamcinolone | Lotion | 0.025% (acetonide) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| benzoyl peroxide | Gel | 4-5% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| benzyl benzoate | Lotion | 25% | |
| permethrin | Cream | 5% | |
| permethrin | Lotion | 1% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acitretin | Tablet | 25mg | |
| isotretinoin | Tablet | 20mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| cyclopentolate | Solution (eye drops) | 1% (hydrochloride) | |
| fluorescein | Injection | 10% | |
| phenylephrine | Solution (eye drops) | 2.5% (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| barium sulfate | Oral liquid | N/A | |
| barium sulfate | Powder for enema | according to availability | |
| dimeglumine gadopentate | Injection | 469 mg/ml | |
| iodamide meglumine | Injection | 65% in 40ml vial | |
| iohexol | Injection | equiv 300mg iodo/ml in 50 or 100ml vial | |
| iohexol | Injection | equiv 350mg iodo/ml in 50 or 100ml vial | |
| iopamidol (iopromide) | Injection | equiv 300 mg iodine/mL in 50 or 100 ml vial | |
| iopamidol (iopromide) | Injection | equiv 370 mg iodine/mL in 50 or 100 mL vial | |
| meglumine iothalamate | Injection | 60% in 50ml vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bisacodyl | Suppository | 10 mg | |
| bisacodyl | Tablet | 5 mg | |
| macrogol 3350 | Powder | with potassium and sodium chloride, sodium bicarbonate, and with or without sodium sulfate | |
| monobasic sodium phosphate + dibasic sodium phosphate | Rectal solution | 16g + 6g/100ml | |
| simethicone | Oral liquid | 80 mg/ml or more (drops) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chlorhexidine | Solution | 7.1% (digluconate) delivering 4% chlorhexidine (for umbilical cord care) | |
| ethyl alcohol (ethanol) | Solution | 70% | |
| hydrogen peroxide | Solution | 3% | |
| iodine-povidone | Topical forms | 7-10% (foam and solution) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| glutaral | Solution | 2% | |
| sodium hypochlorite | Solution | 10% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Solid oral dosage form | 12.5 mg | |
| hydrochlorothiazide | Solid oral dosage form | 25 mg | |
| mannitol | Injectable solution | 20% | |
| spironolactone | Tablet | 100mg | |
| spironolactone | Tablet | 25 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aluminum + magnesium hydroxide | Oral liquid | 400mg + 400mg/5ml | |
| bismuth subsalicylate | Oral liquid | 87.33mg/5ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| pancrea | Injection | 40 mg (sodium salt) | |
| pancrea | Solid oral dosage form | 20 mg | |
| ranitidine | Injection | 25 mg/mL (as hydrochloride) in 2-mL ampoule | |
| ranitidine | Tablet | 150 mg (as hydrochloride) | |
| ranitidine | Tablet | 300mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dimenhydrinate | Injection | 10mg/mL in 5-mL vial | |
| dimenhydrinate | Tablet | 50 mg | |
| metoclopramide | Injection | 5 mg (hydrochloride)/mL in 2-mL ampoule | |
| metoclopramide | Tablet | 10 mg (hydrochloride) | |
| ondansetron | Injection | 2 mg (chlorohydrate)/ml in 4-mL vial | |
| ondansetron | Tablet | 8 mg (chlorohydrate) | |
| promethazine | Injection | 25mg (hydrochloride)/ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| sulfasalazine | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atropine | Injection | 250 mcg/mL | |
| atropine | Injection | 500 mcg (sulfate)/mL | |
| hyoscine hydrobromide | Injection | 20 mg/mL | |
| hyoscine hydrobromide | Tablet | 10 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| oral rehydration salts | Powder | 20.5g/L |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| zinc sulfate | Oral liquid | 10mg | |
| zinc sulfate | Solid oral dosage form | 20 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| monoethanolamine | Injection | 5% (oleate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| betamethasone | Injection | 4 mg (sodium phosphate)/mL | |
| dexamethasone | Injection | 2 mg (phosphate, as sodium salt)/mL in 2-mL vial | |
| dexamethasone | Oral liquid | 2 mg (phosphate, as sodium salt)/5 mL | |
| dexamethasone | Solid oral dosage form | 0.5 mg | |
| dexamethasone | Solid oral dosage form | 4 mg | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
| methylprednisolone | Injection | 100 mg (sodium succinate) | |
| methylprednisolone | Injection | 500 mg (sodium succinate) | |
| prednisone | Oral liquid | 5 mg/5 mL | |
| prednisone | Tablet | 20 mg | |
| prednisone | Tablet | 5 mg | |
| prednisone | Tablet | 50 mg | |
| triamcinolone | Injection | 10 mg/mL in 5-mL vial | |
| triamcinolone | Injection | 40 mg (acetonide)/mL in 1-mL vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chorionic gonadotropin (human) | Injection | 5000 IU/mL | |
| danazol | Tablet | 200 mg | |
| leuprorelin | Injection | 3.75mg | |
| menotropin | Injection | 75 IU |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| alendronic acid | Tablet | 70mg (as alendronate sodium) | |
| pamidronate disodium | Injection | 90 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| testosterone | Injection | 250 mg (enanthate)/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
| levonorgestrel | Tablet | 1.5 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| conjugated estrogens | Tablet | 0.625 mg | |
| conjugated estrogens + medroxyprogesterone | Tablet | 0.625mg + 2.5mg (acetate) | |
| estradiol | Tablet | 1 mg | |
| estriol | Vaginal cream | 0.1% | |
| medroxyprogesterone acetate | Tablet | 5 mg | |
| norethisterone enantate | Oily solution | 200 mg/ml in 1-ml ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| glibenclamide | Tablet | 5 mg | |
| intermediate-acting insulin | Injection | 100 IU/ml in 10-ml vial | |
| metformin | Tablet | 500 mg (hydrochloride) | |
| metformin | Tablet | 850 mg (hydrochloride) | |
| NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clomifene | Tablet | 50 mg (citrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| medroxyprogesterone acetate | Tablet | 5 mg | |
| progesterone | Tablet | 100 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| levothyroxine | Tablet | 50 mcg (sodium salt) | |
| methimazole | Tablet | 20 mg | |
| methimazole | Tablet | 5 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bromocryptin | Tablet | 2.5mg | |
| cabergoline | Tablet | 500 mcg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| tuberculin, purified protein derivative (PPD) | Injection | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| anti rabies human serum | Injection | according to availability | |
| anti-D immunoglobulin (human) | Injection | N/A | |
| anti-hepatitis B immunoglobulin | Injection | 200 UI/ ml | |
| antibothropic serum | Injection | N/A | |
| anticrothalic serum | Injection | N/A | |
| antilachesic serum | Injection | N/A | |
| antiloxoscelic serum | Injection | N/A | |
| antitetanus immunoglobulin (human) | Injection | 250 UI | |
| diphtheria antitoxin | Injection | N/A | |
| tetanus antitoxin | Injection | according to availability |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| BCG vaccine | Injection | N/A | |
| diphtheria vaccine | Injection | adult | |
| diphtheria vaccine | Injection | pediatric | |
| haemophilus influenzae type b vaccine (Hib vaccine) | N/A | N/A | |
| hepatitis A vaccine | N/A | N/A | |
| hepatitis B vaccine | Injection | adult | |
| hepatitis B vaccine | Injection | pediatric | |
| HSUR influenza vaccine | Injection | adult | |
| HSUR influenza vaccine | Injection | pediatric | |
| measles vaccine | Injection | N/A | |
| meningococcal meningitis vaccine | N/A | N/A | |
| mumps vaccine | N/A | N/A | |
| pertussis vaccine | N/A | N/A | |
| pneumococcal vaccine | Injection | adult | |
| pneumococcal vaccine | Injection | pediatric | |
| poliomyelitis vaccine | Injection | N/A | |
| poliomyelitis vaccine | Oral liquid | N/A | |
| rabies vaccine | Injection | inactivated | |
| rabies vaccine | Injection | prepared in infant mouse brain | |
| rotavirus vaccine | N/A | N/A | |
| rubella vaccine | N/A | N/A | |
| tetanus vaccine | Injection | N/A | |
| varicella vaccine | N/A | N/A | |
| yellow fever vaccine | N/A | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atracurium | Injection | 10 mg/mL (besylate) | |
| neostigmine | Injection | 500 mcg (methylsulfate) in 1-mL ampoule | |
| neostigmine | Tablet | 15 mg (bromide) | |
| pyridostigmine | Injection | 1 mg (bromide)/mL | |
| pyridostigmine | Tablet | 60 mg (bromide) | |
| rocuronium bromide | Injection | 10mg/ml | |
| suxamethonium | Injection | 500mg | |
| vecuronium | Injection | 4 mg (bromide)/mL in ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| baclofen | Tablet | 10 mg | |
| orfenadrine | Injection | 30mg (citrate)/ml in 2ml vial | |
| orfenadrine | Tablet | 100mg (citrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aciclovir | Ointment | 3% W/W | |
| ciprofloxacin | Solution (eye drops) | 0.3% | |
| sulfacetamide | Solution (eye drops) | 10-15% (sodium) | |
| tetracycline | Eye ointment | 1% (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| diclofenac | Solution (eye drops) | 0.1% | |
| prednisolone | Solution (eye drops) | 1% (acetate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| proxymetacaine | Solution (eye drops) | 0.5% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetazolamide | Tablet | 250 mg | |
| latanoprost | Solution (eye drops) | 0.005% | |
| pilocarpine | Solution (eye drops) | 2% (hydrochloride or nitrate) | |
| timolol | Solution (eye drops) | 0.5% (maleate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atropine | Solution (eye drops) | 1% (sulfate) | |
| tropicamide | Solution (eye drops) | 1% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ketotifen | Solution (eye drops) | 0.025% | |
| nafazoline | Solution (eye drops) | 0.0125% (chlorohydrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| artificial tears | Gel | 0.3% (eye) | |
| artificial tears | Solution (eye drops) | 0.3% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ergometrine | Injection | 0.2 mg/mL (maleate) in 1-mL ampoule | |
| misoprostol | Vaginal tablet | 25 mcg | |
| oxytocin | Injection | 10 IU in 1-mL ampoule | |
| oxytocin | Injection | 5 IU/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| isoxsuprine | Injection | 5mg (chlorohydrate)/ml in 2ml vial | |
| isoxsuprine | Tablet | 10mg (chlorohydrate) | |
| nifedipine | Immediate-release capsule | 10 mg | |
| salbutamol | Tablet | 4 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| hemodialysis solution | Solution for IV infusion | N/A | |
| hemodialysis solution | Solution for IV infusion | with 35-30 mEq/L bicarbonate | |
| intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 1.5% glucose | |
| intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 2.5% glucose | |
| intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 4.25% glucose |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
| chlorpromazine | Tablet (scored) | 100 mg | |
| clozapine | Tablet | 100mg | |
| clozapine | Tablet | 25mg | |
| fluphenazine | Injection | 25 mg (decanoate or enantate) in 1-mL ampoule | |
| haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
| haloperidol | Injection | 50 mg (as decanoate)/mL | |
| haloperidol | Oral liquid | 2 mg/mL | |
| haloperidol | Tablet | 10 mg | |
| periciazine | Oral liquid | 40mg/ml (1mg/drop) | |
| risperidone | Tablet | 2mg | |
| sulpyride | Tablet | 200mg | |
| thioridazine | Tablet | 100 mg (chlorohydrate) | |
| trifluoperazine | Tablet | 5 mg (chlorohydrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amitriptyline | Tablet | 25 mg | |
| fluoxetine | Solid oral dosage form | 20 mg (as hydrochloride) | |
| mirtazapine | Tablet | 30mg | |
| sertraline | Tablet | 50 mg (chlorohydrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| carbamazepine | Tablet (scored) | 200 mg | |
| lithium carbonate | Solid oral dosage form | 300 mg | |
| valproic acid (sodium valproate) | Tablet (enteric-coated) | 500 mg (sodium valproate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| alprazolam | Tablet | 500 mcg | |
| clonazepam | Tablet | 2mg | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | Tablet (scored) | 10 mg | |
| levomepromazine | Tablet | 100 mg (maleate) | |
| zolpidem | Tablet | 10mg (tartrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clomipramine | Capsule | 25 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| disulfiram | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| methylphenidate | Tablet | 10 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aminophylline | Injection | 25 mg/mL | |
| beclometasone | Inhalation (aerosol) | 250 micrograms (dipropionate) per dose | |
| beclometasone | Metered dose inhaler (aerosol) | 50 micrograms (dipropionate) per dose | |
| epinephrine (adrenaline) | Injection | 1 mg (as hydrochloride or hydrogen tartrate) in 1-ml ampoule | |
| ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
| salbutamol | Metered dose inhaler (aerosol) | 100 mcg (as sulfate) per dose | |
| salbutamol | respirator solution for use in nebulizers | 5 mg (as sulfate)/mL | |
| salmeterol + fluticasone | Metered dose inhaler (aerosol) | 25 mcg + 250mcg/dose | |
| salmeterol + fluticasone | Metered dose inhaler (aerosol) | 25mcg + 125mcg | |
| theophylline | Tablet (prolonged release) | 125 mg | |
| theophylline | Tablet (prolonged release) | 250 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dextromethorphan | Oral liquid | 15mg (hydrobromide)/5ml | |
| surfactant | Injection | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ofloxacin | ear drops | 0.3% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| oral rehydration salts | Powder | 20.5g/L |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| glucose | Parenteral formulation | 10% (1000 mL) | |
| glucose | Parenteral formulation | 33.3% (20 mL) | |
| glucose | Parenteral formulation | 5% (100 mL) | |
| glucose | Parenteral formulation | 5% (1000 mL) | |
| glucose | Parenteral formulation | 5% (250 mL) | |
| glucose | Parenteral formulation | 5% (500 mL) | |
| glucose | Parenteral formulation | 50% (1 L) | |
| glucose with sodium chloride | Injectable solution | 5% glucose, 0.9% sodium chloride (equivalent to 150 mmol/L Na+ and 150 mmol/L Cl-) | |
| polyelectric solution | Parenteral formulation | N/A | |
| potassium chloride | Injection | 20% | |
| ringer lactate solution | Parenteral formulation | 1000ml | |
| sodium bicarbonate | Injection | 8.4% | |
| sodium chloride | Parenteral formulation | 0.9% (1 L) | |
| sodium chloride | Parenteral formulation | 0.9% (100 mL) | |
| sodium chloride | Parenteral formulation | 0.9% (20 mL) | |
| sodium chloride | Parenteral formulation | 0.9% (250 mL) | |
| sodium chloride | Parenteral formulation | 0.9% (5 mL) | |
| sodium chloride | Parenteral formulation | 0.9% (500 mL) | |
| sodium chloride | Parenteral formulation | 20% (20 mL) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| water for injection | Injection | 1L ampoules | |
| water for injection | N/A | 10-ml ampoules | |
| water for injection | N/A | 2-ml ampoules | |
| water for injection | N/A | 5-mL ampoules |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ascorbic acid | Tablet | 100 mg | |
| calcium carbonate | Tablet | 1.25g | |
| calcium gluconate | Injection | 10% | |
| ergocalciferol | Oral liquid | 250 micrograms/ml (10 000 IU/ml) | |
| ergocalciferol | Solid oral dosage form | 1.25 mg (50 000 IU) | |
| folic acid | Tablet | 0.5mg | |
| hydroxocobalamin | Injection | 1 mg/mL | |
| pyridoxine | Tablet | 50mg (chlorohydrate) | |
| retinol | Capsule | 100 000 IU (as palmitate) | |
| retinol | Capsule | 200 000 IU (as palmitate) | |
| retinol | Capsule | 50 000 IU (as palmitate) | |
| thiamine | Injection | 100mg (chlorohydrate)/ml | |
| thiamine | Tablet | 100mg | |
| vitamin D | Injection | 1mcg/ml | |
| vitamin D | Tablet | 250mcg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dimenhydrinate | Injection | 10mg/mL in 5-mL vial | |
| dimenhydrinate | Tablet | 50 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| oxybutynin | Tablet | 5 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| finasteride | Tablet | 5mg | |
| tamsulosin | Tablet | 400mcg |